Category Archives: Top News

Desjardins Sticks to Its Hold Rating for Bank of Montreal

The Financial sector company, Bank of Montreal (TSX: BMO), has received a rating update from a Wall Street analyst yesterday. Analyst Douglas Young from Desjardins remains neutral on the stock and has a C$107 price target. According to TipRanks.com, Young

Apple Inc Receives a Hold from Raymond James

Raymond James analyst Tavis McCourt maintained a Hold rating on Apple Inc (NASDAQ: AAPL) today. The company’s shares opened today at $172.36. According to TipRanks.com, McCourt is a 4-star analyst with an average return of 8.7% and a 62.8% success

Cowen & Co. Sticks to Its Hold Rating for GlaxoSmithKline

Cowen & Co. analyst Steve Scala reiterated a Hold rating on GlaxoSmithKline (NYSE: GSK) yesterday and set a price target of $40. The company’s shares opened today at $37.21. According to TipRanks.com, Scala is a 3-star analyst with an average

Analysts Conflicted on These Healthcare Names: Agios Pharma (NASDAQ: AGIO), Agilent (NYSE: A) and Atara Biotherapeutics (NASDAQ: ATRA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agios Pharma (NASDAQ: AGIO), Agilent (NYSE: A) and Atara Biotherapeutics (NASDAQ: ATRA). Agios Pharma (NASDAQ: AGIO) In a report released today, Anupam Rama from J.P.

Tigress Financial Keeps a Buy Rating on Microsoft Corp

In a report released today, Ivan Feinseth from Tigress Financial reiterated a Buy rating on Microsoft Corp (NASDAQ: MSFT). The company’s shares opened today at $90.81, close to its 52-week high of $96.07. According to TipRanks.com, Feinseth is a 5-star

Fossil Receives a Sell from Buckingham

Buckingham analyst Scott Krasik maintained a Sell rating on Fossil (NASDAQ: FOSL) today and set a price target of $8. The company’s shares closed yesterday at $9.04. According to TipRanks.com, Krasik is a 4-star analyst with an average return of